Commentary · 8 Apr 2026
Review articlePublished 2014
Antivenoms in Snake Envenoming: Are they Safe?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Snake antivenoms are the only definitive management of snake envenoming. Parenteral administration of antivenom mitigates the toxic effects due to snake venom components. However, these benefits come with additional risk of antivenom reactions. The morbidity and mortality of antivenom reactions largely go unnoticed due to lack of awareness and many times these are wrongly attributed to effects of snake venoms. Depending upon the duration between antivenom administration and onset of clinical manifestations, World Health Organization (WHO) has classified these reactions into three types; namely i) early anaphylactic reactions: occur within 10-180 minutes after antivenom infusion, ii) pyrogenic (endotoxic) reactions: develop within 1-2 hours after initiation of treatment, and iii) late reactions: usually develop 1-12 (mean 7) days after treatment. The conjunctival or skin hypersensitivity tests are not only unreliable but can also be sensitizing to antivenom reactions, and hence, not recommended by WHO. The majority of early anaphylactic reactions are non-IgE mediated owing to anticomplementary activity of antivenom and few reactions are attributed to IgE mediated release of anaphylotoxins namely histamines, leukotriens etc. Contamination of antivenom with endotoxins during manufacturing process leads to development of pyrogenic reactions. Late antivenom reactions are the result of production of IgM or IgG antibodies in patients towards antivenom proteins, which ultimately cause formation of immune complexes. The deposition of these immune complexes throughout body leads to manifestations of late reactions. There should be a vigilant approach towards prediction and prevention of antivenom reactions for a better quality of health care.
Subjects
ToxicologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Toxicology.
Perspective · 25 Feb 2026
Toxicological and Health Effects: Mechanisms, Exposure Routes and Prevention Strategies
Case report · 23 Feb 2026
Case Report: Methaemoglobinaemia Following Indoxacarb Ingestion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Toxicology
- SubjectToxicology
- BylineArticles whose byline prints “Deshpande Rushikesh Prabhakar”
- BylineArticles whose byline prints “Motghare Vijay Motiram”
- BylineArticles whose byline prints “Bhamare Chetanran Ghanshyam”
